Pharmaprogress s.r.l.

𝐏𝐡𝐚𝐫𝐦𝐚𝐩𝐫𝐨𝐠𝐫𝐞𝐬𝐬 𝐢𝐬 𝐨𝐟𝐟𝐢𝐜𝐢𝐚𝐥𝐥𝐲 𝐧𝐨𝐰 𝐊𝐲𝐦𝐨𝐬 𝐆𝐫𝐨𝐮𝐩! Dear clients, partners, and followers, As part of our Strategic Plan and international growth, we are unifying our brand identity and communication. Pharmaprogress s.r.l. will now officially be referred to as our Italy Site, operating under the name Kymos Group. This change will combine our multiple-site communication and present a cohesive brand image globally and internationally. Our commitment to providing the same high-quality services and standards remains the same, and our site in Italy will continue to operate with the same excellence you have come to know and expect from us. To stay updated about our most recent news, we ask and invite you to follow our Kymos Group page, as it will be our main and only channel of communication from now on. The current Pharmaprogress s.r.l. page will no longer be active on LinkedIn and will be deactivated in the coming weeks. This change will help us serve you better and keep you informed about all the news related to Kymos Group and the industry. Thank you for your constant support and understanding. Warm regards, Kymos Group Team

↩️ Yesterday, our CEO, Joan Puig de Dou, attended the presentation of BASID: Barcelona's new #LifeScience and #Innovation district, featuring over 4,000 m² of laboratories and development facilities. He joined more than 150 professionals from the Catalonia BioRegion to celebrate the inauguration of this initiative - another milestone in consolidating our ecosystem as a European leader in life sciences innovation.

▶🗓️ Ending the Fairs & Congresses Season of 2024 Over the past few days, our team attended the last events of the year and we've had the chance to connect with new and existing partners and explore potential collaborations at three key industry events. Here’s a quick recap of our journey: ▶ #EBF2024 – Barcelona: Our team had a fantastic time showcasing our bioanalytical services for #SmallMolecules, #Biologics, and #AdvancedTherapies, and attending the comprehensive agenda of presentations and discussions. This event also included a special touch: our Wheel of Fortune! Visitors spun the wheel for a chance to win prizes and the grand winner was Hanna Wartiovaara from Orion Corporation. Congratulations! 🏆🏅 ▶ #PharmaLab2024 – Düsseldorf: In Germany, we had the chance to engage with companies and professionals in the #pharmaceutical industry. ▶ #I4ID2024 – Lyon: Our presence in France brought new connections and partnership possibilities in the premier event focused on innovative strategies to combat #InfectiousDiseases in Europe. Thank you to everyone who made these events so memorable. With this, we close an exciting 2024 events and fairs season, and we look forward to connecting again soon in 2025!

▶ #I4ID2024 Day 1: Connect with Kymos Group in France! While part of our team is in Germany, our dedicated France & Benelux Business Developer, Boris BENOIT, is in Lyon attending the I4ID Congress at the Amphitheatre Charles Mérieux. Visit him at #Booth8 and discover more about Kymos Group's experience in bioanalysis and CMC services for #SmallMolecules, #Biologics, and #AdvancedTherapies. Don’t miss this opportunity to connect with us!

▶#PharmaLab2024: We’ve arrived! Our Commercial Team, Cosme Aragonés, and Judith Oettl are already in Düsseldorf for the PharmaLab Congress, ready to welcome you at #Booth7. Discover our comprehensive portfolio of CMC and bioanalysis services for #SmallMolecules, #Biologics, and #AdvancedTherapies. Whether you have inquiries about our services, wish to explore potential collaborations, or want to connect, they’re here to assist you. Don’t miss the chance—visit us! 👋

▶ Yesterday, our CEO, Joan Puig de Dou, participated as a speaker at the “Business Growth Strategies” session organized by ACCIÓ in Lleida. During the event, Joan shared Kymos Group’s experience with organic and inorganic growth strategies, introducing how these approaches have increased our competitiveness and allowed us to face new challenges. We also had the pleasure of hearing from Jordi Dalmau Vilimelis, Founding Partner and CEO of Solutioma, who offered another valuable perspective on the topic. Thank you to ACCIÓ for hosting such an inspiring session and to all the attendees who made it a success! 💼💡 #KymosGroup #BusinessGrowth #ACCIÓ #GrowthStrategies

▶ #EBF2024 Day 2: Meet Our Team in Barcelona! After an exciting first day of meetings and visits, we’re ready to welcome you to booth #B20 for Day 2 of #EBF2024. Our Laboratory Staff and Marketing & Sales Team are here and ready to connect with you! Don’t miss the chance to explore how Kymos Group can support your needs. Stop by our booth and discuss how we can collaborate to drive your success!

▶ #EBF2024 Day 1: Join us in Barcelona! Our booth (#B20) at the European Bioanalysis Forum is ready, and Cosme Aragonés and Imanol URCOLA LECUONA are excited to welcome you! They're available to discuss our comprehensive portfolio of bioanalytical services for #SmallMolecules, #Biologics, and #AdvancedTherapies, and they will also introduce you to our European laboratories and capabilities. Don’t miss out—stop by and say hello! 👋

▶ Last week, we were delighted to host Dongmin Lee, Quality Assurance at Celltrion Inc., during his visit to our facilities in Cerdanyola del Vallès, Spain. As always, welcoming Celltrion's team to our laboratories was a pleasure, and we look forward to many more years of productive collaboration.

🆕📝 The European Medicines Agency adopted the new "Quality and Equivalence of Topical Products" guideline in October 2024. This document introduces a more structured and stepwise approach to analyzing these dosage forms, focusing on streamlining the process of bringing new generics to market without costly and time-consuming clinical studies. In our latest article, our #IVRT & #IVPT and #QA teams have summarized the most relevant aspects of the EMA guideline on IVRT and IVPT, organizing them into quality and equivalence sections. Learn more about it in our latest blog article: https://lnkd.in/dvYV8Tz8